Artificial intelligence-enhanced echocardiography in cardiovascular disease management


Por: Myhre, PL, Grenne, B, Asch, FM, Delgado, V, Khera, R, Lafitte, S, Lang, RM, Pellikka, PA, Sengupta, PP, Vemulapalli, S and Lam, CSP

Publicada: 1 mar 2026 Ahead of Print: 1 ago 2025
Resumen:
Artificial intelligence (AI) is transforming echocardiography, ushering in an era of improved diagnostic precision, efficiency and patient care. In this Review, we present an in-depth exploration of AI applications in echocardiography, highlighting the latest advances, practical implementations and future directions. We discuss the integration of AI throughout the echocardiographic workflow, from image acquisition and analysis to interpretation. We outline the potential of AI to automate routine measurements and calculations, enable task shifting, recognize disease-specific patterns and uncover new phenogroups that might surpass current diagnostic classifications. Moreover, we address the aspects needed to create trustworthy AI systems, through careful validation, navigating regulatory requirements and upholding ethical standards, thereby presenting a balanced perspective on the advantages and limitations of this rapidly evolving technology. Through an examination of current AI applications, clinical studies and technological breakthroughs, we offer a comprehensive understanding of the evolving role of AI in the future of echocardiography and its capacity to advance cardiovascular care, while also acknowledging the current limitations of the widespread clinical implementation of AI-supported echocardiography.

Filiaciones:
Myhre, PL:
 Univ Oslo, Inst Clin Med, KG Jebsen Ctr Cardiac Biomarkers, Oslo, Norway

 Oslo Univ Hosp, Dept Cardiol, Rikshosp, Oslo, Norway

 Akershus Univ Hosp, Dept Cardiol, Lorenskog, Norway

Grenne, B:
 NTNU Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway

 St Olavs Univ Hosp, Clin Cardiol, Trondheim, Norway

Asch, FM:
 Georgetown Univ, MedStar Hlth Res Inst, Washington, DC USA

 Georgetown Univ, Washington, DC USA

:
 Univ Hosp Germans Trias i Pujol, Heart Inst, Badalona, Spain

Khera, R:
 Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA

 Yale Sch Publ Hlth, Dept Biostat, Sect Hlth Informat, New Haven, CT USA

 Yale Sch Med, Sect Biomed Informat & Data Sci, New Haven, CT USA

 Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT USA

 Yale Sch Med, Cardiovasc Data Sci CarDS Lab, New Haven, CT USA

Lafitte, S:
 Bordeaux Univ, Bordeaux, France

 CHU Bordeaux, Unite Med Chirurgicale valvulopathies, Bordeaux, France

Lang, RM:
 Univ Chicago, Med Ctr, Chicago, IL USA

Pellikka, PA:
 Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA

Sengupta, PP:
 Rutgers Robert Wood Johnson Med Sch, Div Cardiovasc Dis & Hypertens, New Brunswick, NJ USA

Vemulapalli, S:
 Duke Univ, Div Cardiol, Sch Med, Durham, NC USA

 Duke Clin Res Inst, Durham, NC USA

Lam, CSP:
 Natl Heart Ctr, Singapore, Singapore

 Duke Natl Univ Singapore, Singapore, Singapore

 Harvard Med Sch, Baim Inst Clin Res, Boston, MA 02115 USA
ISSN: 17595002





Nature Reviews Cardiology
Editorial
Nature Publishing Group, HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY, Reino Unido
Tipo de documento: Review
Volumen: 23 Número: 3
Páginas: 164-182
WOS Id: 001544163900001
ID de PubMed: 40764834

MÉTRICAS